The Valens Co. buy krebskrebs
Start price
08.02.21
/
50%
€3.78
Target price
08.02.22
€6.60
Performance (%)
-52.38%
End price
09.02.22
€1.80
Summary
This prediction ended on 09.02.22 with a price of €1.80. The BUY prediction by krebskrebs for The Valens Co. performed very badly with a performance of -52.38%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
The Valens Co. | - | - | - | - |
iShares Core DAX® | -1.471% | 1.895% | 25.178% | 22.236% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% | 42.175% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% | 6.454% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% | 42.672% |
Comments by krebskrebs for this prediction
In the thread Valens Groworks Corp diskutieren
Buy mit Kursziel 2,2
In the thread Trading The Valens Co.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten